메뉴 건너뛰기




Volumn 18, Issue 4, 2012, Pages 334-337

Genetic testing by cancer site: Colon (nonpolyposis syndromes)

Author keywords

colorectal; endometrial; Lynch syndrome; microsatellite instability; MLH1; MSH2; MSH6; PMS2

Indexed keywords

ACETYLSALICYLIC ACID; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

EID: 84864575670     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31826094b2     Document Type: Review
Times cited : (12)

References (39)
  • 1
    • 17944362664 scopus 로고    scopus 로고
    • Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
    • Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352:1851-1860.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1851-1860
    • Hampel, H.1    Frankel, W.L.2    Martin, E.3
  • 2
    • 35148901553 scopus 로고    scopus 로고
    • Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
    • Hampel H, Panescu J, Lockman J, et al. Comment on: Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2007;67:9603.
    • (2007) Cancer Res. , vol.67 , pp. 9603
    • Hampel, H.1    Panescu, J.2    Lockman, J.3
  • 3
    • 58849130663 scopus 로고    scopus 로고
    • Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations
    • Barrow E, Robinson L, AlduaijW, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: A report of 121 families with proven mutations. Clin Genet. 2009;75:141-149.
    • (2009) Clin. Genet. , vol.75 , pp. 141-149
    • Barrow, E.1    Alduaijw, R.L.2
  • 4
    • 0029862873 scopus 로고    scopus 로고
    • Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
    • Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-1027.
    • (1996) Gastroenterology , vol.110 , pp. 1020-1027
    • Vasen, H.F.1    Wijnen, J.T.2    Menko, F.H.3
  • 5
    • 20544467125 scopus 로고    scopus 로고
    • Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment
    • Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: Correction for ascertainment. J Med Genet. 2005;42:491-496.
    • (2005) J. Med. Genet. , vol.42 , pp. 491-496
    • Quehenberger, F.1    Vasen, H.F.2    Van Houwelingen, H.C.3
  • 6
    • 79958071334 scopus 로고    scopus 로고
    • Cancer risks associated with germline mutations in MLH1 MSH2 and MSH6 genes in Lynch syndrome
    • Bonadona V, Bonaiti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305:2304-2310.
    • (2011) JAMA , vol.305 , pp. 2304-2310
    • Bonadona, V.1    Bonaiti, B.2    Olschwang, S.3
  • 7
    • 23244443650 scopus 로고    scopus 로고
    • Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset
    • Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset. Gastroenterology 2005;129:415-421.
    • (2005) Gastroenterology , vol.129 , pp. 415-421
    • Hampel, H.1    Stephens, J.A.2    Pukkala, E.3
  • 8
    • 70350090521 scopus 로고    scopus 로고
    • Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
    • Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009;137:1621-1627.
    • (2009) Gastroenterology , vol.137 , pp. 1621-1627
    • Stoffel, E.1    Mukherjee, B.2    Raymond, V.M.3
  • 9
    • 59849129653 scopus 로고    scopus 로고
    • EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
    • Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42-65.
    • (2009) Genet. Med. , vol.11 , pp. 42-65
    • Palomaki, G.E.1    McClain, M.R.2    Melillo, S.3
  • 10
    • 76349108011 scopus 로고    scopus 로고
    • Risks of Lynch syndrome cancers for MSH6 mutation carriers
    • Baglietto L, Lindor NM, Dowty JG, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193-201.
    • (2010) J. Natl. Cancer Inst. , vol.102 , pp. 193-201
    • Baglietto, L.1    Lindor, N.M.2    Dowty, J.G.3
  • 11
    • 48549099663 scopus 로고    scopus 로고
    • The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
    • Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 2008;135:419-428.
    • (2008) Gastroenterology , vol.135 , pp. 419-428
    • Senter, L.1    Clendenning, M.2    Sotamaa, K.3
  • 12
    • 84860605783 scopus 로고    scopus 로고
    • Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
    • Win AK, Young JP, Lindor NM, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol. 2012;30: 958-964.
    • (2012) J. Clin. Oncol. , vol.30 , pp. 958-964
    • Win, A.K.1    Young, J.P.2    Lindor, N.M.3
  • 13
    • 0019515269 scopus 로고
    • The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome
    • Lynch HT, Lynch PM, Pester J, et al. The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med. 1981;141:607-611.
    • (1981) Arch. Intern. Med. , vol.141 , pp. 607-611
    • Lynch, H.T.1    Lynch, P.M.2    Pester, J.3
  • 14
    • 39649093644 scopus 로고    scopus 로고
    • The frequency of Muir-Torre syndrome among Lynch syndrome families
    • South CD, Hampel H, Comeras I, et al. The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst. 2008;100:277-281.
    • (2008) J. Natl. Cancer Inst. , vol.100 , pp. 277-281
    • South, C.D.1    Hampel, H.2    Comeras, I.3
  • 16
    • 0025848680 scopus 로고
    • The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
    • Vasen HF, Mecklin JP, Khan PM, et al The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
    • (1991) Dis Colon Rectum. , vol.34 , pp. 424-425
    • Vasen, H.F.1    Mecklin, J.P.2    Khan, P.M.3
  • 17
    • 0033063711 scopus 로고    scopus 로고
    • New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC
    • Vasen HF,Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999;116:1453-1456.
    • (1999) Gastroenterology , vol.116 , pp. 1453-1456
    • Vasen Hfwatson, P.1    Mecklin, J.P.2
  • 18
    • 0031551963 scopus 로고    scopus 로고
    • A National cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and bethesda guidelines
    • Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997;89:1758-1762.
    • (1997) J. Natl. Cancer Inst. , vol.89 , pp. 1758-1762
    • Rodriguez-Bigas, M.A.1    Boland, C.R.2    Hamilton, S.R.3
  • 19
    • 10744233937 scopus 로고    scopus 로고
    • Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
    • Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-268.
    • (2004) J. Natl. Cancer Inst. , vol.96 , pp. 261-268
    • Umar, A.1    Boland, C.R.2    Terdiman, J.P.3
  • 20
    • 80054081678 scopus 로고    scopus 로고
    • Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: From the revised Bethesda guidelines to a universal approach
    • Morrison J, Bronner M, Leach BH, et al. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: From the revised Bethesda guidelines to a universal approach. Scand J Gastroenterol. 2012;46:1340-1348.
    • (2012) Scand. J. Gastroenterol. , vol.46 , pp. 1340-1348
    • Morrison, J.1    Bronner, M.2    Leach, B.H.3
  • 21
    • 77954720070 scopus 로고    scopus 로고
    • Clinical relevance of microsatellite instability in colorectal cancer
    • de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380-3387.
    • (2010) J. Clin. Oncol. , vol.28 , pp. 3380-3387
    • De La Chapelle, A.1    Hampel, H.2
  • 22
    • 0032534069 scopus 로고    scopus 로고
    • A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
    • Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
    • (1998) Cancer Res. , vol.58 , pp. 5248-5257
    • Boland, C.R.1    Thibodeau, S.N.2    Hamilton, S.R.3
  • 23
    • 57449097359 scopus 로고    scopus 로고
    • Feasibility of screening for Lynch syndrome among patients with colorectal cancer
    • Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783-5788.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 5783-5788
    • Hampel, H.1    Frankel, W.L.2    Martin, E.3
  • 24
    • 0034799747 scopus 로고    scopus 로고
    • The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer
    • Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001;121:830-838.
    • (2001) Gastroenterology , vol.121 , pp. 830-838
    • Samowitz, W.S.1    Curtin, K.2    Lin, H.H.3
  • 26
    • 70449536487 scopus 로고    scopus 로고
    • Epitope-positive truncating MLH1 mutation and loss of PMS2: Implications for IHC-directed genetic testing for Lynch syndrome
    • Zighelboim I, Powell MA, Babb SA, et al. Epitope-positive truncating MLH1 mutation and loss of PMS2: Implications for IHC-directed genetic testing for Lynch syndrome. Fam Cancer. 2009;8:501-504.
    • (2009) Fam. Cancer , vol.8 , pp. 501-504
    • Zighelboim, I.1    Powell, M.A.2    Babb, S.A.3
  • 27
    • 0037083484 scopus 로고    scopus 로고
    • Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors
    • Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043-1048.
    • (2002) J. Clin. Oncol. , vol.20 , pp. 1043-1048
    • Lindor, N.M.1    Burgart, L.J.2    Leontovich, O.3
  • 28
    • 12244278227 scopus 로고    scopus 로고
    • Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours
    • Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002;34:541-547.
    • (2002) Pathology , vol.34 , pp. 541-547
    • Ruszkiewicz, A.1    Bennett, G.2    Moore, J.3
  • 29
    • 34547405167 scopus 로고    scopus 로고
    • Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer
    • Loughrey MB, Waring PM, Tan A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Fam Cancer. 2007;6:301-310.
    • (2007) Fam. Cancer , vol.6 , pp. 301-310
    • Loughrey, M.B.1    Waring, P.M.2    Tan, A.3
  • 30
    • 72749085056 scopus 로고    scopus 로고
    • Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer
    • Hitchins MP, Ward RL. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet. 2009;46:793-802.
    • (2009) J. Med. Genet. , vol.46 , pp. 793-802
    • Hitchins, M.P.1    Ward, R.L.2
  • 31
    • 2342439022 scopus 로고    scopus 로고
    • RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers
    • Mutch DG, Powell MA, Mallon MA, et al. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers. Am J Obstet Gynecol. 2004;190:935-942.
    • (2004) Am. J. Obstet. Gynecol. , vol.190 , pp. 935-942
    • Mutch, D.G.1    Powell, M.A.2    Mallon, M.A.3
  • 32
    • 79952183867 scopus 로고    scopus 로고
    • Genetic counseling considerations in the evaluation of families for Lynch syndromeVa review
    • Weissman SM, Bellcross C, Bittner CC, et al. Genetic counseling considerations in the evaluation of families for Lynch syndromeVa review. J Genet Couns. 2011;20:5-19.
    • (2011) J. Genet. Couns. , vol.20 , pp. 5-19
    • Weissman, S.M.1    Bellcross, C.2    Bittner, C.C.3
  • 33
    • 59849108362 scopus 로고    scopus 로고
    • Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
    • Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35-41.
    • (2009) Genet. Med. , vol.11 , pp. 35-41
  • 34
    • 77149122082 scopus 로고    scopus 로고
    • The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
    • Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12:93-104.
    • (2010) Genet. Med. , vol.12 , pp. 93-104
    • Mvundura, M.1    Grosse, S.D.2    Hampel, H.3
  • 35
    • 79960604164 scopus 로고    scopus 로고
    • Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis
    • Ladabaum U,Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: A cost-effectiveness analysis. Ann Intern Med. 2011;155:69-79.
    • (2011) Ann Intern Med. , vol.155 , pp. 69-79
    • Ladabaum Uwang, G.1    Terdiman, J.2
  • 36
    • 67650383819 scopus 로고    scopus 로고
    • Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
    • Niessen RC, Hofstra RM, Westers H, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer. 2009;48:737-744.
    • (2009) Genes Chromosomes Cancer. , vol.48 , pp. 737-744
    • Niessen, R.C.1    Hofstra, R.M.2    Westers, H.3
  • 37
    • 70350439453 scopus 로고    scopus 로고
    • Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members
    • Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, et al. Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009;27:4793-4797.
    • (2009) J. Clin. Oncol. , vol.27 , pp. 4793-4797
    • Jarvinen, H.J.1    Renkonen-Sinisalo, L.2    Aktan-Collan, K.3
  • 38
    • 84864583824 scopus 로고    scopus 로고
    • NCCN. NCCN Guidelines Version 1.2012: Colorectal Cancer Screening [v.1.2012].
    • NCCN. NCCN Guidelines Version 1.2012 Colorectal Cancer Screening. NCCN Guidelines for Detection, Prevention, and Risk Reduction [v.1.2012]. 2012.
    • (2012) NCCN Guidelines for Detection Prevention and Risk Reduction
  • 39
    • 83955161674 scopus 로고    scopus 로고
    • Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
    • Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet. 378:2081-2087.
    • Lancet , vol.378 , pp. 2081-2087
    • Burn, J.1    Gerdes, A.M.2    MacRae, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.